Base editing, the process used to make the changes, only nicks one strand of DNA, avoiding the major DNA errors that made ...
Base editing in human embryos reveals that NANOG is the one gene required to form every body tissue. Cambridge’s landmark ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than good. A new study from University of California San Diego and Yale ...
Like the human immune system, bacteria learn from past infections. CRISPR sequences—short snippets of DNA from previous viruses—guide destructive enzymes towards invading bacteriophages that express ...
While researchers have long appreciated the enormous potential of genome editing to treat disease, applications of these technologies in humans have historically been limited by safety concerns. Even ...
Clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing is a technology that precisely manipulates the genes in an organism through DNA deletion, insertion, or base ...
Emerging gene-editing platforms are demonstrating that disease-causing mutations, aberrant gene expression, and even large-scale DNA insertions can be corrected without relying on error-prone DNA ...
Affecting an estimated 100,000 people globally, cystic fibrosis (CF) cases stem from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. In the past several decades, ...
The CRISPR-Cas system, originally derived from the adaptive immune mechanism of microbes, functions through the sequence-specific guidance of small RNAs known as guide RNAs (gRNAs). In CRISPR-mediated ...
Microbiome research has faced a hurdle from the get-go: the inability to edit the microbial genome in vivo. Until now, bacterial genomes had to be modified outside—and reintroduced into—the host ...
Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...